2.47 USD
▲+0.45+22.28%
盘后 1.80 0.00%
2026-09-16
市值
$124.04M
市盈率
—
EPS
-0.22
股息率
—
52 周区间
1.17 – 2.57
成交量
1.10M
Beta
0.63
目标价
9.00
52W 低 1.1752W 高 2.57
价格走势
公司简介
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. It develops MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent in Phase 2 clinical trial for treating neurological and other disorders, such as progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, and glioblastoma, as well as prevention of acute res...